A-296 Efficacy and safety of pembrolizumab and radiotherapy in relapsed/refractory cutaneous T cell lymphoma: results of the PORT trial
Titel:
A-296 Efficacy and safety of pembrolizumab and radiotherapy in relapsed/refractory cutaneous T cell lymphoma: results of the PORT trial
Auteur:
Morris, S. Scarisbrick, J. Arumainathan, A. Bates, A. Cheadle, E. Collins, G. Cowan, R. El-Mehidi, N. O'Rourke, N. Osbourne, W. Pawade, J. Robinson, S. Tyson, C. Ward, J. Whittaker, S. Wilson, W. Illidge, T.